Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- Check5 days agoChange DetectedThe page revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedUpdated the study location listing from Padua, Italy 35128 to Padova, Italy 35128.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded new trial locations and local institutions (e.g., Florianópolis, Salvador, Viedma) with investigator contacts, and removed several existing sites; total locations updated to 764.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded new study sites in Krefeld (Germany), Valledupar (Colombia), Floridablanca (Colombia), Bogotá (Colombia), and Buenos Aires (Argentina), updated site contacts, and increased total locations to 761. Montpellier-related entries and other site records were removed or corrected as part of data cleanup.SummaryDifference0.2%

- Check65 days agoChange DetectedAdded site 007-436 in Pergamino, Argentina (B2700KMP) and updated contact details for Eva-Lotte Buchmeier (site 2217) and Ullrich Graeven (site 2221). The total number of locations is now 756.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.